Ranbaxy awaits USFDA nod for mystery drug on Mar 25

CNBC-TV18's Ekta Batra reports that Ranbaxy is to receive an USFDA approval for validation for a particular drug on Monday, March 25 after which it would forfeit opportunities to develop the drug
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead Realasset
moneycontrol.com

Home » News » CNBC-TV18 Comments

Mar 22, 2013, 07.37 PM | Source: CNBC-TV18

Ranbaxy awaits USFDA nod for mystery drug on Mar 25

CNBC-TV18's Ekta Batra reports that Ranbaxy is to receive an USFDA approval for validation for a particular drug on Monday, March 25 after which it would forfeit opportunities to develop the drug

Like this story, share it with millions of investors on M3

Ranbaxy awaits USFDA nod for mystery drug on Mar 25

CNBC-TV18's Ekta Batra reports that Ranbaxy is to receive an USFDA approval for validation for a particular drug on Monday, March 25 after which it would forfeit opportunities to develop the drug

Post Your Comments

Share Cancel

Ekta Batra (more)

Markets Anchor & Financial Analyst, CNBC-TV18 |

Ranbaxy is to receive an USFDA approval for validation for a particular drug on Monday, March 25 after which it would forfeit opportunities to develop the drug going forward, reports CNBC-TV18's Ekta Batra.

However, little is known about the drug. It is code-named ANDA 3 and apparently carries a 180-day exclusivity on it. The drug could range from being very small or similar to Diovan Generic which addresses hypertension.

Ranbaxy had exclusivity on Diovan Generic which expired in September 2012 and has not received USFDA approval for it ever since. Though Ranbaxy’s exclusivity ended on March 21, no other generic participant has received approval for Diovan Generic.

So, pharma industry experts estimate that the deadline of March 25 date could be applicable to Diovan Generic and Ranbaxy’s 180-day exclusivity could possibly start from that date.  

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Ranbaxy awaits USFDA nod for mystery drug on Mar 25

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login